BRIACELL THERAPEUTICS CORP
Institutional coverage
14 13F filers hold $BCTX.
13F holders
14
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
1 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 14 · Source: 13F-HR01
GQG Partners LLC
0.36% of portfolio
216,821 sh
02
PineBridge Investments, L.P.
6.43% of portfolio
147,830 sh
03
Deprince Race & Zollo Inc.
0.11% of portfolio
65,000 sh
04
Banyan Capital Management, Inc.
—
842 sh
05
Brown Capital Management LLC
—
802 sh
06
Fpr Partners LLC
—
200 sh
07
Ameriflex Group, Inc.
—
37 sh
08
New Republic Capital, LLC
—
19 sh
09
Delta Capital Management LLC
—
16 sh
10
Claret Asset Management Corp
—
10 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $BCTX in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $BCTX in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 10:25 UTC.